APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pioglitazone Hydrochloride Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pioglitazone Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025186 pages

Choose your research edition.

Industry ResearchPioglitazone Hydrochloride Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pioglitazone Hydrochloride Capsules Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Pioglitazone Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pioglitazone Hydrochloride Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pioglitazone Hydrochloride Capsules Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pioglitazone Hydrochloride Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pioglitazone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pioglitazone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pioglitazone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pioglitazone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pioglitazone Hydrochloride Capsules include Sandoz, Takeda Pharmaceuticals, Northeast Pharmaceutical Group, Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong, Luote Group, Shandong Xinhua Pharmaceutical and Sichuan Luye Pharmaceutical Industry, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pioglitazone Hydrochloride Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pioglitazone Hydrochloride Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pioglitazone Hydrochloride Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pioglitazone Hydrochloride Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Pioglitazone Hydrochloride Capsules Segment by Company

Sandoz

Takeda Pharmaceuticals

Northeast Pharmaceutical Group

Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong

Luote Group

Shandong Xinhua Pharmaceutical

Sichuan Luye Pharmaceutical Industry

Pioglitazone Hydrochloride Capsules Segment by Type

15mg

30mg

Pioglitazone Hydrochloride Capsules Segment by Application

Hospital and Clinic

Pharmacy

Pioglitazone Hydrochloride Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pioglitazone Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pioglitazone Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pioglitazone Hydrochloride Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pioglitazone Hydrochloride Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pioglitazone Hydrochloride Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pioglitazone Hydrochloride Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pioglitazone Hydrochloride Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pioglitazone Hydrochloride Capsules Industry Trends Table 2. Pioglitazone Hydrochloride Capsules Industry Drivers Table 3. Pioglitazone Hydrochloride Capsules Industry Opportunities and Challenges Table 4. Pioglitazone Hydrochloride Capsules Industry Restraints Table 5. Global Pioglitazone Hydrochloride Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pioglitazone Hydrochloride Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Manufacturers Table 9. Global Pioglitazone Hydrochloride Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pioglitazone Hydrochloride Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pioglitazone Hydrochloride Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pioglitazone Hydrochloride Capsules Manufacturers, Product Type & Application Table 13. Global Pioglitazone Hydrochloride Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pioglitazone Hydrochloride Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 15mg Table 17. Major Manufacturers of 30mg Table 18. Global Pioglitazone Hydrochloride Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pioglitazone Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Pioglitazone Hydrochloride Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2026) Table 22. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2027-2032) Table 23. Global Pioglitazone Hydrochloride Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Pioglitazone Hydrochloride Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Pioglitazone Hydrochloride Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Global Pioglitazone Hydrochloride Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Pioglitazone Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 32. Global Pioglitazone Hydrochloride Capsules Sales by Application (2027-2032) & (K Units) Table 33. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2021-2026) Table 34. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2027-2032) Table 35. Global Pioglitazone Hydrochloride Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Pioglitazone Hydrochloride Capsules Revenue by Application (2021-2026) & (K Units) Table 37. Global Pioglitazone Hydrochloride Capsules Revenue by Application (2027-2032) & (K Units) Table 38. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Application (2021-2026) Table 39. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Application (2027-2032) Table 40. Global Pioglitazone Hydrochloride Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Pioglitazone Hydrochloride Capsules Sales by Region (2021-2026) & (K Units) Table 42. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Region (2021-2026) Table 43. Global Pioglitazone Hydrochloride Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Pioglitazone Hydrochloride Capsules Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 47. North America Pioglitazone Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 48. Europe Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 50. Europe Pioglitazone Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Pioglitazone Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 57. Global Pioglitazone Hydrochloride Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pioglitazone Hydrochloride Capsules Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Pioglitazone Hydrochloride Capsules Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Region (2021-2026) Table 61. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Region (2027-2032) Table 62. Sandoz Company Information Table 63. Sandoz Business Overview Table 64. Sandoz Pioglitazone Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sandoz Pioglitazone Hydrochloride Capsules Product Portfolio Table 66. Sandoz Recent Development Table 67. Takeda Pharmaceuticals Company Information Table 68. Takeda Pharmaceuticals Business Overview Table 69. Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Product Portfolio Table 71. Takeda Pharmaceuticals Recent Development Table 72. Northeast Pharmaceutical Group Company Information Table 73. Northeast Pharmaceutical Group Business Overview Table 74. Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Product Portfolio Table 76. Northeast Pharmaceutical Group Recent Development Table 77. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Company Information Table 78. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Business Overview Table 79. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Product Portfolio Table 81. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Recent Development Table 82. Luote Group Company Information Table 83. Luote Group Business Overview Table 84. Luote Group Pioglitazone Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Luote Group Pioglitazone Hydrochloride Capsules Product Portfolio Table 86. Luote Group Recent Development Table 87. Shandong Xinhua Pharmaceutical Company Information Table 88. Shandong Xinhua Pharmaceutical Business Overview Table 89. Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Product Portfolio Table 91. Shandong Xinhua Pharmaceutical Recent Development Table 92. Sichuan Luye Pharmaceutical Industry Company Information Table 93. Sichuan Luye Pharmaceutical Industry Business Overview Table 94. Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Product Portfolio Table 96. Sichuan Luye Pharmaceutical Industry Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Pioglitazone Hydrochloride Capsules Distributors List Table 100. Pioglitazone Hydrochloride Capsules Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Pioglitazone Hydrochloride Capsules Product Image Figure 2. Global Pioglitazone Hydrochloride Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pioglitazone Hydrochloride Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Pioglitazone Hydrochloride Capsules Sales (2021-2032) & (K Units) Figure 5. Global Pioglitazone Hydrochloride Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pioglitazone Hydrochloride Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 15mg Image Figure 9. 30mg Image Figure 10. Global Pioglitazone Hydrochloride Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Pioglitazone Hydrochloride Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Pioglitazone Hydrochloride Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pioglitazone Hydrochloride Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Global Pioglitazone Hydrochloride Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Pioglitazone Hydrochloride Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2021-2032) Figure 21. Global Pioglitazone Hydrochloride Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pioglitazone Hydrochloride Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Application (2021-2032) Figure 24. North America Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Pioglitazone Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 26. U.S. Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Pioglitazone Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 31. Germany Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Pioglitazone Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 38. China Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 46. Brazil Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Pioglitazone Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Pioglitazone Hydrochloride Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Pioglitazone Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 57. North America Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Pioglitazone Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 59. Europe Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Pioglitazone Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Pioglitazone Hydrochloride Capsules Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Pioglitazone Hydrochloride Capsules Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg
  • 30mg
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • Sandoz
  • Takeda Pharmaceuticals
  • Northeast Pharmaceutical Group
  • Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong
  • Luote Group
  • Shandong Xinhua Pharmaceutical
  • Sichuan Luye Pharmaceutical Industry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pioglitazone Hydrochloride Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pioglitazone Hydrochloride Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pioglitazone Hydrochloride Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pioglitazone Hydrochloride Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pioglitazone Hydrochloride Capsules Market Dynamics
  1. 2.1 Pioglitazone Hydrochloride Capsules Industry Trends
  2. 2.2 Pioglitazone Hydrochloride Capsules Industry Drivers
  3. 2.3 Pioglitazone Hydrochloride Capsules Industry Opportunities and Challenges
  4. 2.4 Pioglitazone Hydrochloride Capsules Industry Restraints
3 Pioglitazone Hydrochloride Capsules Market by Manufacturers
  1. 3.1 Global Pioglitazone Hydrochloride Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pioglitazone Hydrochloride Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pioglitazone Hydrochloride Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pioglitazone Hydrochloride Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pioglitazone Hydrochloride Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pioglitazone Hydrochloride Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Pioglitazone Hydrochloride Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pioglitazone Hydrochloride Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pioglitazone Hydrochloride Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pioglitazone Hydrochloride Capsules Tier 1, Tier 2, and Tier 3
4 Pioglitazone Hydrochloride Capsules Market by Type
  1. 4.1 Pioglitazone Hydrochloride Capsules Type Introduction
  2. 4.1.1 15mg
  3. 4.1.2 30mg
  4. 4.2 Global Pioglitazone Hydrochloride Capsules Sales by Type
  5. 4.2.1 Global Pioglitazone Hydrochloride Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pioglitazone Hydrochloride Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Pioglitazone Hydrochloride Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pioglitazone Hydrochloride Capsules Revenue by Type
  9. 4.3.1 Global Pioglitazone Hydrochloride Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pioglitazone Hydrochloride Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Type (2021-2032)
5 Pioglitazone Hydrochloride Capsules Market by Application
  1. 5.1 Pioglitazone Hydrochloride Capsules Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.2 Global Pioglitazone Hydrochloride Capsules Sales by Application
  5. 5.2.1 Global Pioglitazone Hydrochloride Capsules Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pioglitazone Hydrochloride Capsules Sales by Application (2021-2032)
  7. 5.2.3 Global Pioglitazone Hydrochloride Capsules Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pioglitazone Hydrochloride Capsules Revenue by Application
  9. 5.3.1 Global Pioglitazone Hydrochloride Capsules Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pioglitazone Hydrochloride Capsules Revenue by Application (2021-2032)
  11. 5.3.3 Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Application (2021-2032)
6 Global Pioglitazone Hydrochloride Capsules Sales by Region
  1. 6.1 Global Pioglitazone Hydrochloride Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pioglitazone Hydrochloride Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Pioglitazone Hydrochloride Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Pioglitazone Hydrochloride Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pioglitazone Hydrochloride Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pioglitazone Hydrochloride Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pioglitazone Hydrochloride Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pioglitazone Hydrochloride Capsules Revenue by Region
  1. 7.1 Global Pioglitazone Hydrochloride Capsules Revenue by Region
  2. 7.1.1 Global Pioglitazone Hydrochloride Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pioglitazone Hydrochloride Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Pioglitazone Hydrochloride Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Pioglitazone Hydrochloride Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pioglitazone Hydrochloride Capsules Revenue (2021-2032)
  8. 7.2.2 North America Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pioglitazone Hydrochloride Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pioglitazone Hydrochloride Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pioglitazone Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sandoz
  2. 8.1.1 Sandoz Company Information
  3. 8.1.2 Sandoz Business Overview
  4. 8.1.3 Sandoz Pioglitazone Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sandoz Pioglitazone Hydrochloride Capsules Product Portfolio
  6. 8.1.5 Sandoz Recent Developments
  7. 8.2 Takeda Pharmaceuticals
  8. 8.2.1 Takeda Pharmaceuticals Company Information
  9. 8.2.2 Takeda Pharmaceuticals Business Overview
  10. 8.2.3 Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceuticals Pioglitazone Hydrochloride Capsules Product Portfolio
  12. 8.2.5 Takeda Pharmaceuticals Recent Developments
  13. 8.3 Northeast Pharmaceutical Group
  14. 8.3.1 Northeast Pharmaceutical Group Company Information
  15. 8.3.2 Northeast Pharmaceutical Group Business Overview
  16. 8.3.3 Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Northeast Pharmaceutical Group Pioglitazone Hydrochloride Capsules Product Portfolio
  18. 8.3.5 Northeast Pharmaceutical Group Recent Developments
  19. 8.4 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong
  20. 8.4.1 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Company Information
  21. 8.4.2 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Business Overview
  22. 8.4.3 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Pioglitazone Hydrochloride Capsules Product Portfolio
  24. 8.4.5 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Recent Developments
  25. 8.5 Luote Group
  26. 8.5.1 Luote Group Company Information
  27. 8.5.2 Luote Group Business Overview
  28. 8.5.3 Luote Group Pioglitazone Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Luote Group Pioglitazone Hydrochloride Capsules Product Portfolio
  30. 8.5.5 Luote Group Recent Developments
  31. 8.6 Shandong Xinhua Pharmaceutical
  32. 8.6.1 Shandong Xinhua Pharmaceutical Company Information
  33. 8.6.2 Shandong Xinhua Pharmaceutical Business Overview
  34. 8.6.3 Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shandong Xinhua Pharmaceutical Pioglitazone Hydrochloride Capsules Product Portfolio
  36. 8.6.5 Shandong Xinhua Pharmaceutical Recent Developments
  37. 8.7 Sichuan Luye Pharmaceutical Industry
  38. 8.7.1 Sichuan Luye Pharmaceutical Industry Company Information
  39. 8.7.2 Sichuan Luye Pharmaceutical Industry Business Overview
  40. 8.7.3 Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sichuan Luye Pharmaceutical Industry Pioglitazone Hydrochloride Capsules Product Portfolio
  42. 8.7.5 Sichuan Luye Pharmaceutical Industry Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pioglitazone Hydrochloride Capsules Value Chain Analysis
  2. 9.1.1 Pioglitazone Hydrochloride Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pioglitazone Hydrochloride Capsules Production Mode & Process
  6. 9.2 Pioglitazone Hydrochloride Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pioglitazone Hydrochloride Capsules Distributors
  9. 9.2.3 Pioglitazone Hydrochloride Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst